MedTrace Logo

Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples

NCT01638455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2776

Last updated 2017-05-15

No results posted yet for this study

Summary

Characterize Masimo noninvasive technology in spot check reading on subjects and make comparison to invasive blood sampling tested on reference analyzers.

Conditions

  • Various Comorbidities

Interventions

DEVICE

Noninvasive device

Noninvasive device

Sponsors & Collaborators

  • Masimo Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2016-09-07
Completion
2016-09-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01638455 on ClinicalTrials.gov